Detalhe da pesquisa
1.
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
N Engl J Med
; 386(12): 1109-1120, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320642
2.
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis.
Clin Infect Dis
; 77(6): 892-900, 2023 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227925
3.
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.
Clin Infect Dis
; 70(3): 425-435, 2020 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30942853
4.
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
Clin Infect Dis
; 70(3): 436-445, 2020 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919881
5.
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial.
Lancet Glob Health
; 10(12): e1845-e1854, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400090
6.
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial.
Lancet Infect Dis
; 21(7): 975-983, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587897